Jun 07, 2017 20:30 pm UTC| Business
NEW YORK, June 07, 2017 -- Wolf Haldenstein Adler Freeman Herz LLPannounces that a securities class action lawsuit has been filed in the United State District Court for the Eastern District of New York against Asanko...
TESARO Announces Participation at Goldman Sachs 38th Annual Global Healthcare Conference
Jun 07, 2017 20:30 pm UTC| Business
WALTHAM, Mass., June 07, 2017 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation at the Goldman Sachs 38th Annual Global Healthcare Conference, to be held...
Centrue Financial Corporation Announces Shareholder Approval for Merger
Jun 07, 2017 20:30 pm UTC| Business
OTTAWA, Ill., June 07, 2017 -- Centrue Financial Corporation (NASDAQ:CFCB) (“Centrue”) today announced that Centrue’s shareholders voted in favor of the approval of the merger agreement between Centrue and Midland...
Jun 07, 2017 20:22 pm UTC| Business
STEVENSON, Md., June 07, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the...
Paragon Offshore Announces Confirmation of Restructuring Plan
Jun 07, 2017 20:18 pm UTC| Business
HOUSTON, June 07, 2017 -- Paragon Offshore plc (“Paragon” or the “company”) (OTC:PGNPQ) announced today that the United States Bankruptcy Court has approved the company’s consensual plan of reorganization (the...
Tyson Foods Successfully Completes Acquisition of AdvancePierre
Jun 07, 2017 20:15 pm UTC| Business
SPRINGDALE, Ark., June 07, 2017 -- Tyson Foods, Inc. (NYSE:TSN) has successfully completed the acquisition of AdvancePierre Foods Holdings, Inc., a move aligned with Tyson Foods’ strategic intent to sustainably feed the...
BeiGene to Present at Upcoming Investor Conferences
Jun 07, 2017 20:15 pm UTC| Business
CAMBRIDGE, Mass., June 07, 2017 -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical company developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, today...